BTBR6 transgenic mice have a bidirectional tetracycline-responsive promoter (TRE; tetO) driving expression of two individual fusion genes; the halorhodopsin/EGFP fusion gene (HaloR-EGFP) and channelrhodopsin-2/mCherry fusion gene (ChR2-mCherry). When bred to other mice expressing tTA or reverse tetracycline-controlled transactivator protein (rtTA), simultaneous HaloR-EGFP and ChR2-mCherry expression in the resulting double mutant offspring can be regulated by tetracycline or its analog doxycycline (dox). These mice may be useful for optogenetic studies visualizing neural circuits.
Stephen Rayport, Columbia University and NYSPI
Kenji Tanaka, Columbia University
Genetic Background | Generation |
---|---|
|
Allele Type |
---|
Transgenic (Reporter, Inducible) |
BTBR6 transgenic mice have a bidirectional tetracycline-responsive promoter (TRE; tetO) driving expression of two individual fusion genes; the halorhodopsin/EGFP fusion gene (HaloR-EGFP) and channelrhodopsin-2/mCherry fusion gene (ChR2-mCherry). When bred to other mice expressing tTA or reverse tetracycline-controlled transactivator protein (rtTA), simultaneous HaloR-EGFP and ChR2-mCherry expression in the resulting double mutant offspring can be regulated by tetracycline or its analog doxycycline (dox). The specificity of the tTA strain chosen to generate the bi-transgenic line confers inducible conditional expression of the transgene, and via photostimulation expression of Channelrhodopsin-2, in defined cell populations.
When crossed with a Camk2a-tTA strain (see for example, Stock No. 003010), double transgenic mice show specific expression of EGFP and mCherry in the dorsal striatum and projections into the globus pallidus and substantia nigra, allowing for visualization of neuronal excitability and neural circuits.
A transgenic construct containing a SV40 polyadenylation site sequence (reverse orientation) followed by the halorhodopsin-enhanced green fluorescent protein fusion gene cDNA, and the Channelrhodopsin-2 (Chlamydomonas reinhardtii)/mCherry, Red Fluorescent Protein fusion gene cDNA followed by a SV40 polyadenylation site sequence, under the control of the a bidirectional tetracycline-responsive promoter (TRE; tetO) was injected into fertilized CBA;B6 mouse eggs. Founder line 6 was subsequently established. The mice were then crossed to mice on the B6;129 background for several generations. Upon arrival at The Jackson Laboratory, the mice were crossed to C57BL/6J (Stock No. 000664) at least once to establish the colony.
Expressed Gene | GFP, Green Fluorescent Protein, |
---|---|
Expressed Gene | RFP, Red Fluorescent Protein, coral |
Expressed Gene | COP4, Channelrhodopsin, Chlamydomonas |
Expressed Gene | HOP, Halorhodopsin, Natronomonas |
Site of Expression | When mated to a mutant strain expressing tetracycline-controlled transactivator protein (tTA), expression of HOP/EGFP,COP4/mCherry may be regulated with tetracycline or its analog doxycycline (dox) in the double mutant offspring. The specificity of the tTA strain chosen to generate the bi-transgenic line confers inducible conditional expression of the transgene, and via photostimulation expression of Channelrhodopsin-2, in defined cell populations. For example, when crossed with a Camk2a-tTA strain, double transgenic mice show specific expression of EGFP and mCherry in the dorsal striatum and projections into the globus pallidus and substantia nigra. |
Allele Name | transgene insertion 6, Kenji Tanaka |
---|---|
Allele Type | Transgenic (Reporter, Inducible) |
Allele Synonym(s) | BTR6; Tg(tetO-HOP/EGFP,-COP4/mCherry)6Sray |
Gene Symbol and Name | Tg(tetO-hop/EGFP,-COP4/mCherry)6Kftnk, transgene insertion 6, Kenji Tanaka |
Gene Synonym(s) | |
Promoter | tetO, tet operator, |
Expressed Gene | GFP, Green Fluorescent Protein, |
Expressed Gene | RFP, Red Fluorescent Protein, coral |
Expressed Gene | COP4, Channelrhodopsin, Chlamydomonas |
Expressed Gene | HOP, Halorhodopsin, Natronomonas |
Site of Expression | When mated to a mutant strain expressing tetracycline-controlled transactivator protein (tTA), expression of HOP/EGFP,COP4/mCherry may be regulated with tetracycline or its analog doxycycline (dox) in the double mutant offspring. The specificity of the tTA strain chosen to generate the bi-transgenic line confers inducible conditional expression of the transgene, and via photostimulation expression of Channelrhodopsin-2, in defined cell populations. For example, when crossed with a Camk2a-tTA strain, double transgenic mice show specific expression of EGFP and mCherry in the dorsal striatum and projections into the globus pallidus and substantia nigra. |
Strain of Origin | CBA x C57BL/6 |
Chromosome | UN |
Molecular Note | A bidirectional tetracycline responsive element drives inducible expression of a halorhodopsin/EGFP fusion and a channelrhodopsin-2/m-Cherry fusion. Line 6 was the only line to exhibit expression. |
When maintaining a live colony, these mice can be bred as hemizygotes. The Donating Investigator is attempting to make the strain homozygous.
When using the STOCK Tg(tetO-hop/EGFP,-COP4/mCherry)6Kftnk/J mouse strain in a publication, please cite the originating article(s) and include JAX stock #017906 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
Hemizygous or Non Carrier for Tg(tetO-hop/EGFP,-COP4/mCherry)6Kftnk |
Frozen Mouse Embryo | STOCK Tg(tetO-hop/EGFP -COP4/mCherry)6Kftnk/J Frozen Embryo | $2595.00 |
Frozen Mouse Embryo | STOCK Tg(tetO-hop/EGFP -COP4/mCherry)6Kftnk/J Frozen Embryo | $2595.00 |
Frozen Mouse Embryo | STOCK Tg(tetO-hop/EGFP -COP4/mCherry)6Kftnk/J Frozen Embryo | $3373.50 |
Frozen Mouse Embryo | STOCK Tg(tetO-hop/EGFP -COP4/mCherry)6Kftnk/J Frozen Embryo | $3373.50 |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.